Search for

The European Medicines Agency (EMA) recently began providing open access to clinical data for new medicines for human use authorised in the European Union (EU). Professor David Webb, President of the British Pharmacological Society, comments: “The publication of these r...

In 2014 the British Pharmacological Society joined forces with a partnership of learned societies representing 75,000 scientists to lead the fight against antimicrobial resistance.   Stemming the rise of antimicrobial resistance is one of humanity’s great challenges. UK P...

Membership enquiries Please fill out the form below giving details of your enquiry. The membership team will reply to you as soon as possible. Please note our normal office hours are 9am to 5pm Monday to Friday.

The mission of the British Pharmacological Society is to promote and advance pharmacology. To achieve this goal it is extremely important that we engage with policy. Consequently, the Society produces and endorses a number of statements, ranging from standalone papers and ...

Professor David Webb, President of the British Pharmacological Society, said: It is good to see today’s launch of the new Industrial Strategy leading with a big boost to the life sciences sector, through the creation of nearly 1,000 jobs. The subsequent boost to research an...

The Accelerated Access Review ( AAR ) was commissioned by the government in November 2014. The final report was published on 24 October 2016. It makes recommendations to make it easier for NHS patients to access innovative medicines, medical technologies, diagnostics and dig...

Professor David Webb, President of the British Pharmacological Society, said: The series of investments announced today in the Life Sciences Sector Deal as part of the broader Industrial Strategy demonstrate the value of this vibrant sector to the UK, and it is good to see ...